$NKTX

Nkarta, Inc. (NKTX): Submission of Matters to a Vote of Security Holders

Nkarta, Inc. (NKTX) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K 0001787400 false 0001787400 2026-06-10 2026-06-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10,

Original reporting
Published Jun 11, 2026, 8:59 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 11, 2026, 9:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$NKTX
Neutral
high confidence
Mentioned
$NKTX
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NKTXNeutralLow
01

Why it matters

This provides confirmation of board composition (two Class III directors elected), ratification of Ernst & Young LLP, and the company’s chosen annual frequency for future say-on-pay votes.

02

Market read

Routine governance disclosures; no new fundamental catalyst is introduced.

03

What to watch

Traders may overreact to vote tallies; without accompanying changes (CEO/CFO, financing, trial/regulatory updates), the signal is typically low.

Relevance 6/10Novelty 2/10Timing: after-hours/filing today (2026-06-11) following the June 10 annual meeting

Background

Form 8-K Item 5.07 reports matters submitted to a vote of security holders following the company’s annual meeting.

Company-level read

Ticker impact

$NKTXNeutralHigh confidence
Context

Nkarta filed an 8-K reporting June 10, 2026 annual meeting vote results, including director elections and executive compensation advisory votes.

Expected impact

Likely minimal near-term impact; any reaction would be limited to sentiment around governance outcomes rather than fundamentals.

Evidence & confidence

The 8-K discloses voting tallies and ratification/approval items, not earnings, trials, contracts, financing, or regulatory actions.

Market effects

No direct read-across to biotech/clinical pipeline; this is standard shareholder-meeting reporting.

None.

None.

Counterpoint

If governance outcomes were unusually contentious, it could hint at shareholder dissatisfaction, but the filing provides no narrative or actionable dispute beyond vote counts.

Key entities

  • Nkarta, Inc.

    Company filing the 8-K and reporting annual meeting vote results.

  • Ali Behbahani, M.D., M.B.A.

    Class III director elected at the annual meeting.

  • Zachary Scheiner, Ph.D.

    Class III director elected at the annual meeting.

  • Ernst & Young LLP

    Independent registered public accounting firm ratified for year ending Dec. 31, 2026.

Related articles

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.

$MTZMed

Is MasTec’s Debt Raise and Upgraded Guidance Altering The Investment Case For MasTec (MTZ)?

MasTec (MTZ) completed a $647.76 million fixed-rate senior unsecured notes offering with a 5.85% coupon due Sept. 30, 2036. The company reported Q2 2026 sales of $4,373.55 million and net income of $130.12 million, and raised full-year 2026 revenue guidance to $18.2 billion and GAAP net income to $539 million, citing balance-sheet flexibility and governance updates.